Riga Stock Exchange                                           27.10.2004. 



 

Public JSC Grindeks will co-operate with the Swedish medical chemistry

service company Syntagon



The Swedish medical chemistry service company Syntagon and Latvian manufacturer

of medicaments, Public Joint-Stock Company Grindeks on October 26 have signed 

the memorandum of understanding about the mutual co-operation. According to 

the signed document, the co-operation between Syntagon and Grindeks will take 

place in two stages. 



The first stage will continue from 2005 to the end of 2007 and within this 

stage the co-operation and assistance between both companies are planned in 

development of technologies for implementation of synthesis of active 

pharmaceutical substances, analytical support for fulfilment of synthesis 

projects, manufacture of active pharmaceutical substances as well as other 

kinds of mutually advantageous co-operation.



During the second stage of co-operation after 2007 both contracting parties 

undertake in full extent to actively continue and expand the mutual 

co-operation in implementation of development projects of active pharmaceutical 

substances and execution of orders.



Information prepared by:

Janis Romanovskis, Finance and Administrative Director of the PJSC Grindeks.

Tel.: 7 083 250, 9 226767

e-mail: janis_romanovskis@grindeks.lv